Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date09 Oct 1961 |
100 Clinical Results associated with Keiyo Towa Yakuhin Kk
0 Patents (Medical) associated with Keiyo Towa Yakuhin Kk
100 Deals associated with Keiyo Towa Yakuhin Kk
100 Translational Medicine associated with Keiyo Towa Yakuhin Kk